about
Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirinHepatitis C virus infection and type 1 and type 2 diabetes mellitusThe potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signallingCocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohortVariation of transaminases, HCV-RNA levels and Th1/Th2 cytokine production during the post-partum period in pregnant women with chronic hepatitis C.Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy.The effects of pegylated interferon-α and ribavirin on liver and serum concentrations of activin-A and follistatin in normal Wistar rat: a preliminary reportThe correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome.Pegylated Interferon-α Modulates Liver Concentrations of Activin-A and Its Related Proteins in Normal Wistar Rat.Sarcoidosis and chronic hepatitis C: a case reportExpression profile and kinetics of cytokines and chemokines in patients with chronic hepatitis CCryoglobulinaemia in Egyptian Patients with Extrahepatic Cutaneous Manifestations of Chronic Hepatitis C Virus Infection.Blocking type I interferon signaling rescues lymphocytes from oxidative stress, exhaustion, and apoptosis in a streptozotocin-induced mouse model of type I diabetes.Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infectionSOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment.Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?Serum Activins and Follistatin during the Treatment of Chronic Hepatitis C Genotypes 1 and 4 and Their Correlations with Viral Load and Liver Enzymes: A Preliminary Report.The role of chemokines in acute and chronic hepatitis C infection.Targeting Hepatic Fibrosis in Autoimmune Hepatitis.Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies.In vitro infection of primary human hepatocytes by HCV-positive sera: insights on a highly relevant model.Hepatitis C virus infection of a thyroid cell line: implications for pathogenesis of hepatitis C virus and thyroiditis.HLA-G regulatory polymorphisms are associated with susceptibility to HCV infection.Type I Interferon Elevates Co-Regulatory Receptor Expression on CMV- and EBV-Specific CD8 T Cells in Chronic Hepatitis C.Effects of chronic hepatitis C genotype 1 and 4 on serum activins and follistatin in treatment naïve patients and their correlations with interleukin-6, tumour necrosis factor-α, viral load and liver damage.Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature.Model of the adaptive immune response system against HCV infection reveals potential immunomodulatory agents for combination therapy.Restoring Inflammatory Mediator Balance after Sofosbuvir-Induced Viral Clearance in Patients with Chronic Hepatitis C.
P2860
Q26784321-8E9584AF-C9EC-4157-8ED3-050149156F68Q26829202-658C5A09-D0A7-4C64-B586-88E1C1E3C83AQ28087571-415FACF4-1691-44EA-9EC2-700DFAA4329BQ34097854-A6B3543E-1454-432E-9160-71959110DB04Q35018340-53C13FD8-AE37-4AD5-BBAB-31C3745C4196Q35563500-110AD42D-3C3D-4ED3-8674-84BE369F5D5AQ35674832-4FA4ADD2-CBD2-44FF-8053-B55066C67793Q35861413-772474D5-6DAE-40F3-851C-BC9224507C88Q35864762-EE11BF24-2A04-44D8-AE4F-9F122830CF5FQ36357512-7CE11E17-074C-466A-9FA7-2EA13DA9EC02Q36411689-A06F5C12-3A41-4EA8-AEDD-85E6D8FC426BQ36453659-3DA7264A-389F-4B55-86F2-9B7479ED8436Q36711831-F1F98EE8-F77A-49FE-B0C8-8BDFDE55A313Q37282559-69BCC0CA-BB9B-43B5-B748-19BE0EE686CEQ37358513-4737CBE3-B41C-405E-B42E-898FA7A74269Q37408923-D9BAF12F-5BBA-4850-B79F-D480CFCDE0CCQ37715878-151A4BF7-49E6-4C87-9EDF-FE567054EC75Q38129709-115A57D8-C34D-4773-A306-ED4D6BFD7C5CQ38902371-87A2D027-A009-4C87-B814-1CEC9DCBC89AQ38994989-70E0F541-E075-41FA-9BB7-6E5295DB2985Q39072381-A087AA77-4621-40E2-ACC8-EAD75197C106Q39222504-98E0459A-769B-4FF5-B109-131CEF7E9F69Q40373358-37428910-7BC9-42F1-B264-8797F06BE971Q40794710-960FBD24-73C8-4D6C-B412-B3D84FAD718DQ42212782-95CD946F-B1AC-469B-94AA-84543236438BQ47555610-827CC640-FF7D-4783-914F-38E471C926C1Q55400314-935766E5-0341-4159-807C-E6D02B5BFDEDQ55436171-1717BBFE-EA7E-4E0B-9902-6B681001469C
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cytokines and HCV-related disorders.
@ast
Cytokines and HCV-related disorders.
@en
type
label
Cytokines and HCV-related disorders.
@ast
Cytokines and HCV-related disorders.
@en
prefLabel
Cytokines and HCV-related disorders.
@ast
Cytokines and HCV-related disorders.
@en
P2093
P2860
P921
P356
P1476
Cytokines and HCV-related disorders.
@en
P2093
Alda Corrado
Alessandro Antonelli
Clodoveo Ferri
Poupak Fallahi
Silvia Martina Ferrari
P2860
P304
P356
10.1155/2012/468107
P5008
P577
2012-05-07T00:00:00Z